ClinicalTrials.govpublic full text
Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
peripheral arterial disease, peripheral vascular diseases, lower limb ischemia, atherosclerosis of artery, atherosclerosis, montelukast, leukotrienes, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848664
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.